ClinicalKey vs UpToDate: cost, content and which one to pay for yourself

ClinicalKey is priced in public. On Elsevier's US store in September 2026, the Essentials package costs $29 a month or $299 a year and starts with a 15 day free trial. Specialty packages, which add your field's journals and reference books, run $60 to $125 a month or $500 to $750 a year depending on the specialty. Elsevier also sells six Extended Specialty packages for sub-specialists at $125 to $200 a month or $1,040 to $1,250 a year. Paying annually is cheaper than twelve monthly payments on every package: on Essentials it is $299 against $348. The full tier-by-tier breakdown is on our ClinicalKey subscription cost page.

UpToDate is not. Wolters Kluwer publishes no individual price at any tier. The store asks for your country, then one of four roles (Professional, Student or Resident, Purchase for groups/others, Other), then your profession, and the practicing clinician route stops at a login before any figure appears. The annual numbers you see quoted on directory sites were not published by the vendor, and we do not repeat them. Every route in, including trainee and group rates, is documented on our UpToDate subscription page.

So the only fair cost comparison is this: ClinicalKey Essentials at $299 a year against whatever the UpToDate store quotes you for your role, minus the value of the CME credit UpToDate earns you. Run the UpToDate store to the quote before you decide. If the number is more than double ClinicalKey Essentials, the CME has to be worth a lot to you for UpToDate to win on price alone.

For a bedside decision, most clinicians find UpToDate faster, and that is the core of the difference. UpToDate topics are written by named physician authors, edited, and given explicit grades, so the recommendation is already there when you open the page. The oldest comparisons still ranking for this query, both from 2013, reached the same conclusion: clinicians tended to favor UpToDate for patient care and ClinicalKey for research and reading.

ClinicalKey's answer to that is its clinical overviews, short synopses that sit on top of the full-text library and link out to the chapters and drug monographs behind them. They make ClinicalKey workable at the point of care, and they are included in every package. They are not the same thing as a graded UpToDate topic, and you will still read more to reach a decision.

Where ClinicalKey is clearly stronger is depth of source. You get the actual textbook chapter, the procedural video before you do the procedure, and on specialty packages the full text of journals such as The Lancet. UpToDate cites the literature; ClinicalKey hands it to you. If you teach, write, or want to see the primary evidence yourself, that is worth more than a faster summary.

Many people searching this comparison actually mean ClinicalKey AI, Elsevier's conversational product, which is sold separately from the ClinicalKey library. On Elsevier's subscription site in September 2026 it costs $349 a year or $39 a month after 90 days free, and it is free for a year for US and Canadian medical students. Answers cite Elsevier's books, journals and clinical references, and Elsevier awards 0.5 CME credit for each response you review, which it says can be submitted toward Maintenance of Certification for boards such as ABIM.

That makes ClinicalKey AI the closer rival to UpToDate on the thing UpToDate is best at: a quick answer with CME attached. The difference is authorship. An AI answer is generated from sources at the moment you ask; an UpToDate recommendation was written and graded by people before you asked. Some clinicians want the first for speed and the second when the decision is heavy. If you are weighing free AI tools as well, our UpToDate vs OpenEvidence comparison covers the ad-funded alternative.

If you are leaving a hospital or a training program and can afford only one, decide by how you use it. If most of your lookups end in "what do I do now", buy UpToDate, and let the CME it accrues offset part of the price. If most of them end in "let me read about this properly", or you work in a specialty that lives in its journals, buy a ClinicalKey specialty package. If you are cost-sensitive and want a real reference rather than a free app, ClinicalKey Essentials at $299 a year is the lowest published price for a full clinical reference; what UpToDate costs an individual is worth reading before you commit to either.

Two other priced options belong on the shortlist. DynaMedex, from EBSCO, publishes $599 a year for an UpToDate-style evidence summary with a 60 day money-back window, and BMJ Best Practice sells individual plans priced in pounds. We compare the first head to head in UpToDate vs DynaMed. If your practice needs several seats, group pricing changes the answer, and our institutional licensing guide covers where individual plans stop making sense.

Before paying for anything, ask the medical library at any hospital where you hold privileges. Library access to ClinicalKey and UpToDate is common, and plenty of clinicians pay for a subscription they could have used for free.

Both include drug content, and neither is a pharmacy-grade compendium on its own terms. ClinicalKey carries drug monographs for US prescription drugs, OTC, herbal and supplement products, linked from its clinical overviews. UpToDate integrates Lexidrug, the former Lexicomp database, including its interaction checker, which is one of the stronger reasons clinicians who prescribe heavily lean toward UpToDate. Wolters Kluwer also sells Lexidrug on its own at $29.99 a month, and we compare the two in Lexicomp vs UpToDate.

If drug information is the main reason you are buying, a dedicated drug database may be the better purchase than either. Elsevier's own Clinical Pharmacology lists a $650 12 month individual plan with Trissel's IV compatibility and toxicology, covered in Clinical Pharmacology subscription cost.

ClinicalKey and UpToDate are both references. You ask, they answer, and both assume you know which question to ask. The prescribing errors that hurt patients mostly happen where nobody asked: the interacting drug already on the home list, the creatinine that came back after the order went in, the allergy recorded two admissions ago.

Prescriber.io is built for that moment rather than for reading. You enter the drug and the patient's scenario once, and one card returns interactions across the whole list, contraindications, allergy blockers, renal and hepatic dose adjustments and guideline-based alternatives, each with a cited source, for a licensed clinician to review and sign. It is priced per clinician per month and it sits beside whichever reference you keep. If you are replacing UpToDate rather than adding to it, our UpToDate alternative page lays out the other options.